Advertisement

Fennec Pharmaceuticals Inc. FRX.TO

Set alert

Price alert · FRX.TO

All alert types
14.83 CAD +0.05 +0.34%

As of Oct 30, 9:40 AM ET

14.83 Day range 15.08
7.59 52-week range 17.64
YTD
+39.91%
1 year
+23.58%
Open
15.08
Prev close
14.78
Mkt cap
520.05M
Vol
200
Avg vol
462
EPS
-0.17
P/E
0.00
Div yield
0.00%
More statistics
Low
14.83
High
15.08
Forward P/E
0.00
Beta
0.27
Short ratio
7.66
Inst. own
54.70%
Dividend
0.00
Ex-div date
50-d avg
7.13
200-d avg
9.13
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Dec 17, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (83)
NameDateAgo
MACD: Buy SignalOct 21, 20261 week ago
RSI: OversoldOct 15, 20262 weeks ago
SMA: BearishSep 15, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
MACD: Buy SignalAug 28, 20262 months ago
MACD: Sell SignalAug 21, 20262 months ago
RSI: OverboughtAug 11, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
RSI: OverboughtAug 7, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BearishJul 30, 20263 months ago
MACD: Sell SignalJul 9, 20263 months ago
MACD: Buy SignalJun 23, 20264 months ago
RSI: OverboughtJun 23, 20264 months ago
MACD: Sell SignalJun 3, 20265 months ago
RSI: OverboughtJun 2, 20265 months ago
SMA: BullishMay 14, 20265 months ago
SMA: BullishMay 14, 20265 months ago
RSI: OverboughtMay 14, 20265 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BullishMay 6, 20265 months ago
MACD: Buy SignalApr 8, 20266 months ago
RSI: OversoldMar 24, 20267 months ago
SMA: BearishMar 6, 20268 months ago
SMA: BearishMar 3, 20268 months ago
MACD: Sell SignalMar 3, 20268 months ago
SMA: BullishFeb 17, 20268 months ago
RSI: OverboughtFeb 17, 20268 months ago
SMA: BearishFeb 11, 20268 months ago
SMA: BullishFeb 5, 20268 months ago
MACD: Buy SignalFeb 5, 20268 months ago
MACD: Sell SignalJan 30, 20269 months ago
MACD: Buy SignalDec 19, 202510 months ago
SMA: BearishDec 2, 202511 months ago
MACD: Sell SignalNov 25, 202511 months ago
SMA: BearishNov 21, 202511 months ago
SMA: BullishNov 20, 202511 months ago
SMA: BearishNov 19, 202511 months ago
SMA: BullishNov 17, 202511 months ago
MACD: Buy SignalNov 17, 202511 months ago
SMA: BearishOct 29, 20251 year ago
SMA: BullishOct 23, 20251 year ago
SMA: BearishOct 17, 20251 year ago
SMA: BullishOct 16, 20251 year ago
SMA: BearishOct 14, 20251 year ago
MACD: Sell SignalOct 10, 20251 year ago
MACD: Buy SignalSep 29, 20251 year ago
SMA: BullishSep 25, 20251 year ago
SMA: BearishSep 23, 20251 year ago
MACD: Sell SignalSep 15, 20251 year ago
MACD: Buy SignalAug 25, 20251 year ago
SMA: BullishAug 22, 20251 year ago
MACD: Sell SignalAug 19, 20251 year ago
SMA: BearishAug 18, 20251 year ago
SMA: BullishAug 15, 20251 year ago
SMA: BearishAug 14, 20251 year ago
SMA: BullishAug 12, 20251 year ago
MACD: Buy SignalAug 12, 20251 year ago
SMA: BearishJul 31, 20251 year ago
MACD: Sell SignalJul 15, 20251 year ago
MACD: Buy SignalJul 4, 20251 year ago
MACD: Sell SignalJun 11, 20251 year ago
RSI: OverboughtJun 6, 20251 year ago
RSI: OverboughtMay 28, 20251 year ago
RSI: OverboughtMay 16, 20251 year ago
RSI: OverboughtMay 8, 20251 year ago
SMA: BullishMay 5, 20251 year ago
MACD: Buy SignalApr 25, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
SMA: BearishMar 27, 20251 year ago
SMA: BullishMar 14, 20251 year ago
SMA: BearishMar 13, 20251 year ago
SMA: BullishMar 11, 20251 year ago
SMA: BearishMar 10, 20251 year ago
MACD: Sell SignalMar 6, 20251 year ago
MACD: Buy SignalFeb 28, 20251 year ago
SMA: BullishFeb 21, 20251 year ago
SMA: BearishFeb 20, 20251 year ago
MACD: Sell SignalFeb 7, 20251 year ago
MACD: Buy SignalJan 27, 20251 year ago
SMA: BullishJan 24, 20251 year ago
SMA: BearishJan 23, 20251 year ago
RSI: OverboughtNov 26, 20241 year ago

Key statistics

Market cap
244.42M
Enterprise value
226.88M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
4.95
Price / book
0.00
EPS (TTM)
-0.06
Beta
0.27
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-2.30%
Revenue (TTM)
49.35M
Revenue growth
7.00%
Free cash flow
-3.40M
Total cash
40.32M
Total debt
32.10M
Return on equity
0.00%
Shares outstanding
27.43M
Short % of float
0.13%
50-day average
7.13
200-day average
9.13

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 0.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate 0.2538.

Earnings history

Upgrades / downgrades

FRX.TO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.reitBuyBuy
Aug 22, 2024HC Wainwright & Co.mainBuyBuy
Aug 14, 2024Craig-HallummainBuyBuy
May 15, 2024Craig-HallummainBuyBuy
May 15, 2024HC Wainwright & Co.mainBuyBuy
Apr 4, 2024HC Wainwright & Co.mainBuyBuy

About Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on FRX.TO — it syncs with the Stock Master app.

Insider holders

FRX.TO insider holders
InsiderRelationLatest transactionDateShares held
ANDRADE ROBERT CChief Financial OfficerStock Award(Grant)Dec 1, 2024128,423
HAIGH ADRIAN JChief Operating OfficerSaleApr 21, 20240
ISLAM KHALIDDirectorConversion of Exercise of derivative securityNov 15, 2023213,825
RALLIS CHRISTOPHER ANIGERONDirectorSaleDec 1, 202452,214
RAYKOV ROSTISLAV CHRISTOVDirectorSaleDec 4, 202466,432

Institution ownership

FRX.TO institution ownership
Holder% heldSharesValueReported
Southpoint Capital Advisors Lp14.84%4,077,21436.33MSep 29, 2024
Sonic Gp LLC 8.76%2,407,35721.45MSep 29, 2024
Solas Capital Management, LLC7.00%1,923,53617.14MSep 29, 2024
DG Capital Management, LLC5.54%1,522,20413.56MSep 29, 2024
Blackrock Inc.4.48%1,229,47710.95MSep 29, 2024
Vanguard Group Inc3.81%1,047,8919.34MSep 29, 2024

Fund ownership

FRX.TO fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund3.19%876,2087.81MSep 29, 2024
iShares Russell 2000 ETF2.04%559,3714.98MOct 30, 2024
Fidelity Small Cap Index Fund0.88%241,0182.15MAug 30, 2024
iShares Russell 2000 Value ETF0.60%165,5101.47MOct 30, 2024
Vanguard Russell 2000 Index Fund0.34%94,580842.71KAug 30, 2024
Schwab Capital Trust-Small Cap Index Fund0.20%55,452494.08KJul 30, 2024
Advertisement